European pharmaceutical exports to Morocco reached 314.9 million euros for the first nine months of 2026, a 6.8% decline compared to the same period in 2025.
While September saw a 47.6% rebound to 40.9 million euros, the trend reflects a complex rebalancing of supply chains across the European Union.
- Total export value for the first three quarters of 2026 reached 314.9 million euros, down from 337.8 million euros in 2025.
- September volume surged to 561.4 tonnes, a 16.3% increase, with the average value per kilogram rising to 72.8 euros.
- Belgium, Germany, and the Netherlands accounted for 16.8 million euros in additional supply during September, offsetting declines in French shipments.
Nine-month aggregate data reveals a large turnover in the Moroccan import market. France remains the primary supplier at 116.5 million euros, though this represents an 11.4% contraction from 131.5 million euros in the prior year. Germany experienced a sharper decline, with its market share value falling 37.4% to 51.1 million euros, according to data from Eurostat.
Conversely, secondary suppliers have gained ground. Belgium moved into the second position with 56.9 million euros in deliveries, a 6.4% increase. Spain and the Netherlands also expanded their presence, reporting growth of 35.3% and 38.9%, respectively.
| Country | 9-Month 2026 Value (Millions €) | Change vs. 2025 (%) |
|---|---|---|
| France | 116.5 | -11.4 |
| Belgium | 56.9 | +6.4 |
| Germany | 51.1 | -37.4 |
| Spain | 29.8 | +35.3 |
| Netherlands | 27.1 | +38.9 |
While “other packaged medications” remain the largest category, their value fell 7% to 235.3 million euros over the nine-month period. In contrast, hormonal and steroid-based medications saw a 13.8% increase to 37 million euros.
While the average price per kilogram rose 27% in September to 72.8 euros, the year-to-date average price dropped to 58 euros per kilogram from 61.2 euros. The decline in total tonnage—from 5,517.8 tonnes to 5,430.7 tonnes—coupled with this price compression, indicates that Moroccan importers face a volatile procurement environment where unit costs and logistics fluctuate monthly.
Preparations containing insulin, which accounted for 3.2 million euros in imports through September 2025, dropped to zero for the same period in 2026. Other categories, such as alkaloid-based preparations, saw their import value nearly halved to 2.9 million euros.
Ces chiffres, calculés par Barlamane.com d’après les données douanières d’Eurostat mises à jour le 13 novembre, montrent des évolutions contrastées dans les livraisons de différentes catégories de médicaments européens vers le Maroc. As the market heads into the final quarter of 2026, the cumulative deficit of 22.9 million euros compared to 2025 is a key benchmark for importers and European exporters alike.